Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...

Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more ...

Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.

A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by ...

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...

NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.

We recently published a list of Jim Cramer Talked About These 13 Stocks. In this article, we are going to take a look at ...

With COVID cases rising in India and several other countries, many people are wondering whether they should get vaccinated.

The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by ...

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...